cromolyn + terbutaline

Cromolyn + terbutaline is a combination therapy used primarily in the management of asthma, particularly in pediatric patients. Cromolyn is a mast cell stabilizer that prevents the release of inflammatory mediators from sensitized mast cells, thereby reducing airway inflammation and preventing bronchospasm. Terbutaline is a selective beta-2 adrenergic receptor agonist that acts as a bronchodilator by relaxing smooth muscle in the airways through increased cyclic AMP levels. The combination has been shown to improve symptom control and lung function compared to terbutaline alone, and may allow for reduction in corticosteroid dosage without worsening asthma symptoms[1][3]. Cromolyn does not relieve acute bronchospasm but is effective for prophylactic use; terbutaline provides rapid bronchodilation[5][4].